Home›Companies›Biotech & Pharma›PushCART Therapeutics

PushCART Therapeutics, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Jul 31, 2026·Suggest an edit

About PushCART Therapeutics

PushCART Therapeutics is a private company based in Rockville, Maryland, incorporated in 2025 in Delaware. It has reported $500,000 raised in one offering on Form D since July 2026. Its chief executive is Stephen Wolpe.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 10, 2026Jul 31, 2026$500,000of $2.0M target1$500KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on PushCART Therapeutics's Form D filed Jul 31, 2026.

SR
Sean Reineke
Director
LW
Louis Weiner
Director
AH
Albert Hawk
Director
SW
Stephen Wolpe
CEO and director

Sources

  1. SECPushCART Therapeutics, Inc. filing history
  2. ResearchGeorgetown University new venture showcase